Astera Labs (ALAB) Q2 2024 earnings summary

Executive summary

• Achieved record Q2 2024 revenue of $76.9 million, up 18% sequentially and 619% year-over-year, driven by strong AI platform demand, Aries product sales, and new product cycles.

• Non-GAAP operating margin was 24.4% and non-GAAP EPS was $0.13; non-GAAP net income reached $22.2 million.

• Completed IPO in March 2024, raising $672.2 million in net proceeds and converting all preferred stock to common stock.

• Expanded global footprint with a new R&D center in India and a cloud-scale interop lab in Taiwan.

• Operating expenses increased due to non-cash stock-based compensation and higher headcount.

Financial highlights

• Q2 2024 revenue: $76.9 million (+18% QoQ, +619% YoY); non-GAAP gross margin: 78.0%; GAAP gross margin: 77.9%.

• Q2 2024 non-GAAP operating income: $18.7 million; non-GAAP net income: $22.2 million.

• Q2 2024 net loss: $7.5 million; six-month net loss: $100.5 million, impacted by IPO-related stock-based compensation.

• Cash, cash equivalents, and marketable securities totaled $831.0 million at June 30, 2024.

• Net cash provided by operating activities in H1 2024: $33.5 million; investing activities used $306.7 million.

Outlook and guidance

• Q3 2024 revenue expected between $95 million and $100 million, with non-GAAP gross margin ~75%.

• Non-GAAP operating expenses projected at $46–$47 million; non-GAAP EPS expected at $0.16–$0.17.

• GAAP operating expenses projected at $92–$93 million; GAAP diluted loss/share expected at $0.06–$0.08.

• Management expects R&D and S&M expenses to increase in absolute dollars but decline as a percentage of revenue over time.

• Liquidity expected to fund operations for at least the next 12 months and beyond.